<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>medicine prices &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/medicine-prices/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Oct 2026 21:03:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>medicine prices &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nationwide cross-sectional survey finds varied pricing relationships in 63 fixed-dose and free-equivalent groups in China’s NRDL</title>
		<link>https://bioengineer.org/nationwide-cross-sectional-survey-finds-varied-pricing-relationships-in-63-fixed-dose-and-free-equivalent-groups-in-chinas-nrdl/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 21:03:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[between]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[fixed-dose combinations]]></category>
		<category><![CDATA[free-equivalent combinations]]></category>
		<category><![CDATA[health services research]]></category>
		<category><![CDATA[medicine prices]]></category>
		<category><![CDATA[National Reimbursement Drug List]]></category>
		<category><![CDATA[prices]]></category>
		<category><![CDATA[reimbursement category]]></category>
		<category><![CDATA[relationship]]></category>
		<category><![CDATA[therapeutic areas]]></category>
		<category><![CDATA[volume-based procurement]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=443328</guid>

					<description><![CDATA[A nationwide cross-sectional study of 63 FDC–FEC groups found a median fixed-dose-to-free-equivalent unit-price ratio of 0.94, with differences associated with therapeutic area and reimbursement category.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">443328</post-id>	</item>
	</channel>
</rss>
